SARS-CoV-2 vaccine in patients with systemic sclerosis: Impact of disease subtype and therapy.
Percival Degrava Sampaio-BarrosAna Cristina Medeiros-RibeiroAna Paula Luppino-AssadRenata MiossiHenrique Carriço da SilvaEmily F V N YukiSandra G PasotoCarla G S SaadClóvis A SilvaLéonard V K KupaGiordano B H DevezaTatiana N PedrosaNádia E AikawaEloisa S BonfaPublished in: Rheumatology (Oxford, England) (2021)
ClinicalTrials.gov, https://clinicaltrials.gov, NCT04754698.